Dark Forest Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Dark Forest Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-45,319	Closed	-$832K	–	1201
2024 Q4	$832K	Sell	45,319 -29,225	-39%	-$472K	0.12%	221
2024 Q3	$1.15M	Buy	74,544 +41,634	+127%	+$695K	0.15%	142
2024 Q2	$535K	Buy	+32,910	New	+$531K	0.1%	256
2023 Q4	–	Sell	-95,735	Closed	-$2M	–	435
2023 Q3	$2M	Buy	95,735 +30,769	+47%	+$836K	0.15%	129
2023 Q2	$1.56M	Buy	64,966 +56,388	+657%	+$1.25M	0.14%	136
2023 Q1	$161K	Buy	+8,578	New	+$163K	0.04%	485
2022 Q1	–	Sell	-232	Closed	-$5K	–	1213
2021 Q4	$5K	Sell	232 -415	-64%	-$8.35K	﹤0.01%	1132
2021 Q3	$11K	Buy	+647	New	+$12.5K	﹤0.01%	965

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dark Forest Capital Management's ACAD Position: Q1 2025 in Review

Dark Forest Capital Management sold out of Acadia Pharmaceuticals (ACAD) in Q1 2025, closing a stake of 45,319 shares — an estimated $832K sold.

Dark Forest Capital Management first reported a position in ACAD in Q3 2021 and held it in 8 quarters. The position peaked at $2M in Q3 2023. 320 funds tracked by Wall St. Rank hold ACAD as of Q1 2025.

Dark Forest Capital Management reported no remaining Acadia Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Dark Forest Capital Management sold 45,319 Acadia Pharmaceuticals shares in Q1 2025, an estimated $832K.
Dark Forest Capital Management first reported a position in Acadia Pharmaceuticals in Q3 2021 and held it in 8 quarters.
Dark Forest Capital Management's Acadia Pharmaceuticals position peaked at $2M in Q3 2023.
320 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2025.

Based on Dark Forest Capital Management's 13F filing for Q1 2025, filed 15 May 2025.